Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06429436 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vending Machine Naloxone Distribution for Your Community (VENDY)

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting Primary completion moved earlier from Jun 30, 2026 to Feb 28, 2026 · Site details revised at 3 of 3 sitesv5 Show 2 more changesShow less
    • Primary completion moved earlier from Jun 30, 2026 to Feb 28, 2026
    • Site details revised at 3 of 3 sites
  2. Primary completion date: Jan 1, 2026 to Jun 30, 2026v4
  3. Enrollment target: 1489 to 4000 Primary completion date: Jun 1, 2025 to Jan 1, 2026 · Completion date: Jan 1, 2026 to Jun 30, 2026 · Collaborators revised (3)v3 Show 3 more changesShow less
    • Primary completion date: Jun 1, 2025 to Jan 1, 2026
    • Completion date: Jan 1, 2026 to Jun 30, 2026
    • Collaborators revised (3)

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 3v2 Show 1 more changeShow less
    • Study sites: 0 to 3
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.
Trial Details
NCT Number NCT06429436
Lead Sponsor University of Colorado, Denver
Collaborators: Southern Colorado Harm Reduction Association, Denver Health and Hospital Authority, Summit County Public Health
Conditions Harm Reduction, Naloxone, Opioid Overdose
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov